# L-glutamine Gut Health Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/l-glutamine-gut-health-randomized-trial-evidence-review
Category: evidence-review
Summary: L-glutamine Gut Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-05-22
Reviewed by: Migaku Evidence Review
# L-glutamine Gut Health Randomized Trial: What the Evidence Says

## Quick Answer

L-glutamine Gut Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials | systematic review | 1 | 2026-04-10 | 10.3389/fnut.2026.1778464 |
| High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health | narrative review | 3 | 2026-02-14 | 10.3748/wjg.v32.i6.113804 |

## What The Sources Report

- In the United States alone, the annual healthcare cost associated with postoperative ileus is estimated to exceed 1.4 billion dollars. [Zhang Yuqiang (2026); evidence level 1]
- High-protein diets have dual effects on metabolic dysfunction-associated steatotic liver disease, depending on protein source and amount. [Yin Hong-Yuan (2026); evidence level 3]
- Patients with metabolic dysfunction-associated steatotic liver disease should favor plant proteins and limit animal proteins; personalized dietary strategies require further mechanistic research. [Yin Hong-Yuan (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For l-glutamine gut health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Yuqiang (2026). The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1778464. PMCID: PMC13106113. PMID: 42039896. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13106113/
- Yin Hong-Yuan (2026). High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health. DOI: 10.3748/wjg.v32.i6.113804. PMCID: PMC12898319. PMID: 41695277. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12898319/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.